• Meet the DSRU team at ICPE Prague!

    The DSRU team will be attending the 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) in Prague next week. Visit the DSRU Booth (#26) to find out about our capabilities: DSRU Consultancy ECHO – for observational studies on mental health products World-class PASS studies in primary and secondary care Listen to our oral presentations (see […]

    >Continue reading
  • UK vote for continued involvement with EMA post-Brexit

    The DSRU welcomes the UK’s decision to have continued involvement in EU medicines regulation after Brexit. The UK Parliament voted last night for the UK to participate in the regulatory network operated by the European Medicines Agency (EMA) after it leaves the EU. The government confirmed that it would make an “appropriate financial contribution” in […]

    >Continue reading
  • DSRU Consultancy: World class science at a not-for-profit price

    Saad Shakir writes: DSRU Consultancy provides consultancy and advice on matters related to Pharmacovigilance, Pharmacoepidemiology, Risk Management and Risk Minimisation. The DSRU consultants are a team of epidemiologists, physicians, biomedical scientists, IT and data management professionals, who provide the consultancy work individually or as a team. We advise all kinds of companies from the some […]

    >Continue reading
  • Blog: Measuring the Impact of Pharmacovigilance 

    Saad Shakir writes: Huge efforts and resources have been allocated to Pharmacovigilance around the world, with enormous progress in the last two decades. Signal Detection, Risk Management and Risk Minimisation are only a few examples of fairly recent developments.  The effects of these and other developments in Pharmacovigilance are real and there are metrics that measure […]

    >Continue reading